Public Company News

First Patient Dosed in the Registrational Phase III Study of Olverembatinib in Treatment-Naïve Patients with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

SUZHOU, China and ROCKVILLE, Md., Oct. 17, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the registrational Phase III study (HQP1351AG...

2023-10-18 10:11 2193

ExcelFin Acquisition Corp. Announces Adjournment of Special Meeting

NEW YORK, Oct. 17, 2023 /PRNewswire/ -- ExcelFin Acquisition Corp. ("we", "us", "our", or the "Company"), today announced that the Special Meeting originally scheduled forOctober 18, 2023 (the "Special Meeting") is being adjourned to October 20, 2023. At the Special Meeting, the Company's stockho...

2023-10-18 05:20 4050

PUYI Fund, a subsidiary of Puyi Inc. (NASDAQ: PUYI), and Ping An Bank Co., Ltd. Have Entered Into Strategic Cooperation Agreement To Explore A New Model of Bank-Enterprise Collaboration

GUANGZHOU, China , Oct. 17, 2023 /PRNewswire/ -- PUYI Fund, a subsidiary of Puyi Inc. ("Puyi" or the "Company") (NASDAQ: PUYI), a renowned asset management company, and Ping An Bank Co., Ltd., a leading financial institution, recently announced that they have formally entered into a strategic coo...

2023-10-17 22:07 4316

ATIF Holdings Limited client Global Mofy Metaverse Limited, announces the pricing of IPO and Nasdaq listing

IRVINE, Calif., Oct. 17, 2023 /PRNewswire/ -- Global Mofy Metaverse Limited, has successfully listed on NASDAQ, which is the first Chinese company to be successfully listed on Nasdaq after the implementation of the China Securities Regulatory Commission's new rules for overseas listing filing.. ...

2023-10-17 21:00 4253

Baijiayun Announces Change in Management

BEIJING, Oct. 17, 2023 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (Nasdaq: RTC), a one-stop AI video solution provider, today announced a change in its management. Mr. Yong Fang has tendered his resignation as the chief financial officer of the Company, effective fromOcto...

2023-10-17 20:00 4477

WiMi Will Build Data Interaction Platform for AIGC

BEIJING, Oct. 17, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that a variety of technologies such as computer science, artificial intelligence, natural language proc...

2023-10-17 20:00 2429

Canadian Solar Successfully Issues a JPY 18.5 Billion Green Samurai Private Placement in Japan

GUELPH, ON, Oct. 17, 2023 /PRNewswire/ -- Canadian Solar Inc. (the "Company", or "Canadian Solar") (NASDAQ: CSIQ) today announced the successful placement of aJPY 18.5 billion green samurai private placement ("private placement"). Goldman Sachs Japan Co., Ltd. ("G...

2023-10-17 19:00 3909

Baidu Launches ERNIE 4.0 Foundation Model, Leading a New Wave of AI-Native Applications

* ERNIE 4.0 is now accessible to invited users on ERNIE Bot. In addition, enterprise customers can apply for API testing via BaiduQianfan foundation model platform . * Baidu has re-built many of its most popular applications using...

2023-10-17 17:22 3822

WuXi Biologics Launches New High-Productivity Bioprocessing Platform WuXiUI™ for Cost-Effective Commercial Manufacturing and Desirable Product Quality

* WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics development and manufacture. The platform can significantly improve productivity and quality, and reduce cost-of-goods (COGS) in commercial manufacturin...

2023-10-17 08:30 2605

CANbridge Announces NDA Acceptance of CAN108 (邁芮倍®/LIVMARLI®) for Cholestatic Pruritus in Progressive Familial Intrahepatic Cholestasis (PFIC) by China's National Medical Products Administration

BEIJING and BURLINGTON, Mass., Oct. 16, 2023 /PRNewswire/ -- CANbridge Pharmaceuticals Inc. (HKEX:1228), a global biopharmaceutical company, with a foundation inChina,  committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announ...

2023-10-17 08:00 16218

WeTrade Group Inc. Upgrades its China Business to Drive Multi-Faceted Growth

BEIJING, Oct. 16, 2023 /PRNewswire/ -- WeTrade Group Inc. ("WeTrade" or the "Company") (NASDAQ: WETG), a global diversified "software as a service" ("SaaS") technology service provider committed to offering technical support and digital transformation tools for enterprises across various industri...

2023-10-17 05:36 4744

Abbisko will debut two blockbuster clinical research results at the 2023 European Society for Medical Oncology(ESMO)

SHANGHAI, Oct. 16, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) announced that the clinical results of first-in-human study of FGFR4 inhibitor Irpagratinib(ABSK011)and the clinical results of first-in-human dose-escalating of PD-L1 inhibitor ABSK043 with...

2023-10-16 21:50 2734

LITEON Power Innovations Showcases Installation of Level 3 DC Fast Charger with Partner

TAIPEI, Oct. 16, 2023 /PRNewswire/ -- LITEON Technology (2301.tw) continues to set industry milestones with its latest portfolio addition: a Level 3 Electric Vehicle (EV) DC fast charger. Launched by Power Innovations International (Pii) - a subsidiary of LITEON - these EV chargers easily integra...

2023-10-16 21:30 3421

New Study Demonstrates Lunit SCOPE IO's Effectiveness to Predict Biliary Tract Cancer Therapy Outcomes - Findings to be Presented at the ESMO 2023

- Nine abstracts, featuring the effectiveness of Lunit's AI-powered TIL/WSI analyzer and biomarker platform, accepted by the ESMO 2023 Congress SEOUL, South Korea, Oct. 16, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeut...

2023-10-16 21:10 2802

TaiMed Announces Significant Progress in Clinical Trials for New HIV Treatment

Company champions long-acting HIV therapy with new biologic drug TMB-365/380 combination; after favorable results of Phase1b/2a, company plans to accelerate Phase 2 clincial study to expedite path to market TAIPEI, Oct. 16, 2023 /PRNewswire/ -- TaiMed Biologics

2023-10-16 21:00 2613

ATIF Formally Signs $2.4 million Advisory Agreement with Rawrr, Inc.

IRVINE, Calif., Oct. 16, 2023 /PRNewswire/ -- ATIF Holdings Limited (NASDAQ: ATIF, hereinafter referred to as the "Company" or "ATIF") announces that its subsidiary, ATIF Business Management LLC, has entered into a definitive agreement with Rawrr, Inc. (hereinafter referred to as the "Rawrr") to ...

2023-10-16 21:00 3445

MultiMetaVerse Announces Listing Transfer to Nasdaq Capital Market

SHANGHAI, Oct. 16, 2023 /PRNewswire/ -- MultiMetaVerse Holdings Limited ("MMV" or the "Company"), an animation and entertainment company for young consumers in China, announced today that it has received a letter of approval from the Listing Qualifications Department of the Nasdaq Stock Market ("N...

2023-10-16 20:50 3378

POSCO Group Devotes Its Full Resources to Support Busan's Bid for World Expo 2030

* With the commitment to serve as ambassadors supporting Busan's bid for World Expo 2030, all POSCO Group employees actively contribute to the group's daily efforts to attract this global event. * Chairman Jeong-woo Choi of POSCO Group reached out to global society for support, and the group'...

2023-10-16 20:00 2912

WiMi Developed Multi-modal EEG-Based Hybrid BCI System with Visual Servo Module

BEIJING, Oct. 16, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it developed multi-modal EEG-based hybrid BCI system with visual servo module which combines SSVEP...

2023-10-16 20:00 2364

I-Mab Announces Phase 1 Data of Givastomig at ESMO 2023

ROCKVILLE, Md. and SHANGHAI, China, Oct. 16, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapie...

2023-10-16 20:00 2669
1 ... 436437438439440441442 ... 748